期刊文献+

托吡酯与丙戊酸钠对婴幼儿癫痫体重及相关代谢指标的影响 被引量:4

Weight and relevant metabolism index changes in epileptic infant who taking sodium valproate or topiramate
原文传递
导出
摘要 【目的】观察托吡酯(topiramate,TPM)与丙戊酸钠(sodium valproate,VPA)对婴幼儿癫痫患者体重及相关代谢指标的影响。【方法】选择首次单独服用TPM、VPA的婴幼儿癫痫患者各30例为治疗组,同期健康体检婴幼儿20例为对照组。治疗组在治疗前及治疗后3个月、对照组在首次体检时及3个月后分别测定体重、甘油三酯(triglycer-ide,TG)、总胆固醇(total cholesterol,TC)、早晨空腹血糖、胰岛素、瘦素水平。【结果】TPM组治疗3个月后患儿体重增长较缓慢,血清TG、TC、胰岛素、瘦素均较对照组明显下降(P<0.05),早晨空腹血糖值两组间差异无显著性(P>0.05)。VPA组治疗3个月后患儿体重增长加速,血清TG、TC、胰岛素、瘦素均较对照组明显增加(P<0.05),早晨空腹血糖值两组间差异无显著性(P>0.05)。【结论】TPM可使婴幼儿体重增长缓慢,并降低TG、TC、胰岛素、瘦素水平;VPA可使婴幼儿体重增长加速,并升高TG、TC、胰岛素、瘦素水平;TPM、VPA对血糖无明显影响。TPM、VPA对婴幼儿癫痫患者生长发育有一定影响。 [Objective] To observe weight and relevant metabolism index changes in epileptic infant who taking sodium valproate(VPA) or topiramate(TPM). [Methods] Two group with 30 epileptic infant were treated with sodium valproate or topiramate. Weight, triglyceride, total cholesterol, blood--fasting sugar, insulin and serum leptin were measured before and after three months treatment. At the same time 20 health infant were as control. [Results] Triglyceride, total cholesterol, insulin and serum leptin were decreased significantly at TPM group(P〈0.05). While there were no significant differences in weight and blood fasting sugar after three months treatment(P〉0.05). Weight, triglyceride, total cholesterol, blood-fasting sugar, insulin and serum leptin were decreased significantly at VPA group(P〈0.05). While there was no significant difference in blood--fasting sugar after three months treatment(P〉0.05). [Conclusions] Triglyeeride, total cholesterol, insulin and serum leptin are decreased,while weight is decreased after treated with TPM. Triglyceride, total cholesterol, insulin and serum leptin and weight were increased after treated with VPA. TPM,VPA could have significant effect in epileptic infant,while will not effect on blood-fasting sugar of theirs.
作者 陈峰 黄绍平
出处 《中国儿童保健杂志》 CAS 2009年第6期643-645,共3页 Chinese Journal of Child Health Care
基金 陕西省科技攻关项目(2007K15-01)
关键词 托吡酯 丙戊酸钠 婴幼儿 癫痫 胰岛素 瘦素 topiramate valproate infant epileptic insulin serum leptin
  • 相关文献

参考文献17

  • 1林庆.小儿癫癎发作的分类及最新进展[J].中华儿科杂志,2002,40(5):313-315. 被引量:28
  • 2Ben-menachem E, Axelsen M, Johanson EH, et al. Predictors of weight loss in adults with topiramate-treated epilepsy[J].Obes Res,2003,11(4):556-562.
  • 3Nickel MK,Nickel C,Muehlbacher M,et al. Influence of topi- ramate on olanzapine-related adiposity in women: a random, double-blind,placebo-controlled study[J].J Clin Psychopharmacol,2005,25(3) :211-217.
  • 4Piqueras AI,White RH,Raafat F,et al. Renal biopsy diagnosis in children presenting with haematuria[J]. Pediatr Nephrol, 1998,12(5) :386-391.
  • 5Luef G, Abramham I, Haslinger M, et al. Polycystic ovaries, obesity and insulin resistance in women with epilepsy,a comparative study of carbamazepine and valproic acid in 105 women[J]. J Neurol, 2002,249 (7) : 835-841.
  • 6Biton V,Levisohn P, Hbyler S, et al. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy:results from a post hoc analysis of a randomized, double-blind clinical trial[J]. J Child Neurol, 2003,18: 133-139.
  • 7Erean D, Sabiha A. Weight gain associated with valproate in children[J]. Pediatric Neurology, 2000, 22 : 361-364.
  • 8Richard D, Ferland J, Lalonda J, et al. Influence of topiramate in the regulation of energy balance[J]. Nutrition, 2000, 16 (10) :961-966.
  • 9李静,李丹,黄绍平.妥泰、丙戊酸钠对成年及幼年大鼠血清瘦素和胰岛素水平的影响[J].中国当代儿科杂志,2007,9(3):229-232. 被引量:4
  • 10王克玲,施荣富,田杰,李清华,杨花芳,郑华成,孙素真.托吡酯对癫患儿糖代谢的影响[J].中国实用儿科杂志,2005,20(3):148-150. 被引量:6

二级参考文献31

  • 1沈上,韩济生.甘丙肽研究进展[J].生理科学进展,1995,26(2):155-158. 被引量:15
  • 2林庆 许积德 等.全国小儿神经病学专题讨论会纪要:关于小儿癫痫临床分类和治疗的建议[J].中华儿科杂志,1984,22:100-101.
  • 3Wilding JP. Neuropeptides and appetite control. Diabct Med, 2002,19(8) :619-627.
  • 4Zdrojewicz Z, Sowinska E, Sztuka Pietkiewicz A. The role of galanin in the endocrine ,system. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw,2000,6(2) : 129-134.
  • 5Yamaji K, Yoshitomi T, Usui S. Effect of somatostatin and galanin on isolated rabbit iris sphincter and dilator muscles. Exp Eye Res,2003,77(5) :609-614.
  • 6Sliwinski W. Action of galanin on smooth muscle strips isolated from rat and human uterus. Ginckol Pol, 2003,74 ( 3 ) : 210-214.
  • 7Mitchell V, Lecompte F, Beauvillain JC. Regulation of galanin receptor galR1 mRNA expression by ovarian steroids in oestrogen receptor alpha-immunoreactive neurones: identification of distinct populations of neurones in the prcoptic area. Neuroendocrinology,2004,16(2) : 138-145.
  • 8Kerekes N, Mennicken F, O' Donnell D, et al. Galanin increases membrane excitability and enhances (Ta^2^+ currents in adult.acutely dissociated dorsal root ganglion neurons. Eur J Neurosci, 2003, 18( 11 ) :2957-2966.
  • 9Mennicken F, Hoffert C, Pelletier M, et al. Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J Chem Neuroanat, 2002,24 (4) ; 257-268.
  • 10Smiarowska M. Lcptin and it's potential role in the pathomechanism of some hormonal and metabolic disorders of patients with anorexia nervosa. Ann Acad Med Stetin, 2002,48 (3) : 351-365.

共引文献34

同被引文献35

  • 1韩蕴丽,刘敏.妥泰治疗儿童癫癎32例临床分析[J].广西医科大学学报,2004,21(3):441-442. 被引量:1
  • 2施荣富,王克玲,李清华,郑华城,杨华芳,唐红霞,孙素真,王丽辉,田杰.托吡酯治疗后癫癎患儿体重和血浆甘丙肽的变化[J].中华儿科杂志,2007,45(3):199-202. 被引量:4
  • 3吴瑞萍,胡亚美,江载芳,主编.实用儿科学[M].6版.北京:人民卫生出版社,2000:1172.
  • 4Proposal for revised clinical and electroencephalographicclassification of epileptic seizures. From the commis-sion on classification and terminology ofthe internation-al league against epilepsy[J]. Epilepsia,1981,22 (4):489-501.
  • 5Ogawa Y,Kikuchi T,Nagasaki K? et al. Usefulness ofserum adiponectin level as a diagnostic marker of meta-bolic syndrome in obese Japanese children[J], Hyper-tens Res,2005 ,28 : 51-57.
  • 6McElroy SL, Hudson JI, Capece JA, et al. Topiramatefor the treatment of binge eating disorder associatedwith obesity: a placebo-controlled study[J]. Biol Psychi-atry, 2007 ,61(9) : 1 039-1 048.
  • 7Li HF,Zou Y,Xia ZZ,et al. Effects of topiramate onweight and metabolism in children with epilepsy [J].Acta Paediatr,2009,98(9):1 521-1 525.
  • 8Schutt M, Brinkhoff J?Drenckhan M, et al. Weight Re-ducing and Metabolic effects of topiramate in Patientswith migraine-an Observational Study[J]. Exp Clin En-docrinol Diabetes,2010,118(7) :449-452.
  • 9Narula PK, Rehan HS,Unni KE, et al. Topiramate forprevention of olanzapine associated weight gain andmetabolic dysfunction in schizophrenia: a double-blind,placebo-controlled trial[J]. Schizophr Res,2010,118(1-3):218-223.
  • 10Nakanishi H, Yonezawa A, Matsubara K, et al. Impact of P-glycopro- tein and breast cancer resistance protein on the brain distribution of an- tiepileptic drugs in knockout mouse models [ J]. Eur J Pharmacol, 2013,710( 1-3 ) :20-28.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部